5Sreenan C,Osiovich H.Myeloid colony-stimulating factors use in the mewborn[J].Archives of Pediatrics & Adolescent Medicine,1999,153:984-988.
6Sigita L,Audrius S,Elona J,et al.Safety and efficacy study of the recombinant granulocyte colony-stimulating factor for prevention of neutropenia and neutropenia-related complications in women with metastatic breast cancer receiving docetaxel/doxorubicin[J].Medicina(Kaunas),2009,45(8):600-606.
7Saito K,Nakamara Y,Aoyagi M,et al.Low dose cytarabine and aclarubrcin in combination with granulocyte colony stimulating factor for previousely treated patients with repladsed or primary resistant acute myeloid leukemia and refractory anemia with excessblast in transformation[J].Int J Hematol,2000,7(1):238-244.
8Kano Y,Akutsu M,Tsunoda S,et al.In vitro cytotoxiceffects of fludarabine in combination with commonly used antileukemic agents by isobologram analysis[J].Leukemia,2000,14(3):379-388.
9Hyeoung JK,Hasun-eup,Hasun-gun,et al.The clinical outcome of FLAG chemotherapy without idarubicin in patients with relapsed or refractory acute myeloid leukemia[J].J Korean Med Sic,2009,24:498-503.
10Hu J,Takatoku M,Sellers SE,et al.Analysis origin and optimization of expansion and transduction of circulating peripheral blood endothelial progenitor cells in the rhesus macaque model[J].Hum Gene Ther,2002,13:2041-2050.
